Soft tissue sarcomas are rare, but early, accurate diagnosis with subsequent appropriate
treatment is crucial for the clinical outcome. The ESSR guidelines are intended to help …

OBJECTIVE. Soft-tissue sarcomas are a diverse group of malignancies, and our rapidly
improving understanding of their molecular pathogenesis and treatment is leading to better …

The relatively low incidence and often atypical clinical presentation of soft-tissue sarcomas
(STS) impedes early and adequate diagnosis. Patients may report on recently enlarged soft …

Soft-tissue sarcomas are uncommon and heterogeneous tumors of mesenchymal origin. A
soft-tissue mass that is increasing in size, greater than 5 cm, or located under deep fascia …

Soft-tissue sarcomas are a rare and heterogeneous group of diseases with variable biology
and pattern of metastases. These characteristics make it challenging to conduct large …

INTRODUCTION: To investigate the adequacy of current early referral guidelines for patients
with extremity soft tissue sarcomas. PATIENTS & METHODS: 365 patients with confirmed …

ABSTRACT Background Soft-tissue sarcomas (STSs) are rare tumors with varied
histological presentations. Management and treatment are thus complex, but crucial for …

BACKGROUND Because soft tissue sarcomas (STS) are rare, guidelines for the diagnosis
and treatment of patients with STS were developed. Because the diagnostic management is …

Background: Soft tissue sarcomas are challenging to oncologists due to their unique
character, the infrequency of their occurrence, and the difficulties in predicting outcomes …

Background Managing soft-tissue sarcoma (STS) relies on histologic grade, which is the
strongest prognostic factor and a routine assessment at biopsy. However, underestimation of …